Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Nathan Standifer"'
Autor:
Elizabeth L. Hardaker, Emilio Sanseviero, Ankur Karmokar, Devon Taylor, Marta Milo, Chrysis Michaloglou, Adina Hughes, Mimi Mai, Matthew King, Anisha Solanki, Lukasz Magiera, Ricardo Miragaia, Gozde Kar, Nathan Standifer, Michael Surace, Shaan Gill, Alison Peter, Sara Talbot, Sehmus Tohumeken, Henderson Fryer, Ali Mostafa, Kathy Mulgrew, Carolyn Lam, Scott Hoffmann, Daniel Sutton, Larissa Carnevalli, Fernando J. Calero-Nieto, Gemma N. Jones, Andrew J. Pierce, Zena Wilson, David Campbell, Lynet Nyoni, Carla P. Martins, Tamara Baker, Gilberto Serrano de Almeida, Zainab Ramlaoui, Abdel Bidar, Benjamin Phillips, Joseph Boland, Sonia Iyer, J. Carl Barrett, Arsene-Bienvenu Loembé, Serge Y. Fuchs, Umamaheswar Duvvuri, Pei-Jen Lou, Melonie A. Nance, Carlos Alberto Gomez Roca, Elaine Cadogan, Susan E. Critichlow, Steven Fawell, Mark Cobbold, Emma Dean, Viia Valge-Archer, Alan Lau, Dmitry I. Gabrilovich, Simon T. Barry
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract The Ataxia telangiectasia and Rad3-related (ATR) inhibitor ceralasertib in combination with the PD-L1 antibody durvalumab demonstrated encouraging clinical benefit in melanoma and lung cancer patients who progressed on immunotherapy. Here we
Externí odkaz:
https://doaj.org/article/189773f2417346dcbdf8b6281d57effa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/3dee369a999a4541ad801162edd36c34
Autor:
Dara Burdette, Thomas Dubensky, Nathan Standifer, Henry Johnson, Alyssa Mullenix, Anja Holtz, Dave Freund, Valerie Chen, David Hsieh, Jesus Garcia Lopez, Jamie Cope, Peppi Prasit, Anne Moon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ca78ca8b3c1f47f78fdbc08e6d55ce0d
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 7, Pp 436-439 (2019)
Externí odkaz:
https://doaj.org/article/e498c2c66e18416c9c5622c8ec4baa7e
Autor:
Carl Barrett, Maria Ascierto, Song Wu, Nathan Standifer, Melissa de los Reyes, Micheal Oberst, Rajv Raja
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5c3d2d7a986d4daa8ddca0615a24657c
Autor:
Julio C. Chavez, Francine M. Foss, Basem M. William, Jonathan E. Brammer, Sonali M. Smith, Anca Prica, Jasmine M. Zain, Joseph M. Tuscano, Harsh Shah, Neha Mehta-Shah, Praveen Ramakrishnan Geethakumari, Ben X. Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, Anmarie Boutrin, Weiguang Zhao, Lily Cheng, Nathan Standifer, Lisa Hewitt, Enowmpey Enowtambong, Weiping Shao, Shringi Sharma, Gianluca Carlesso, Jeffrey A. Moscow, Lillian L. Siu
Publikováno v:
Clinical Cancer Research. 29:1869-1878
Purpose: Proliferation of T-follicular helper (TFH) CD4+ T cells is a postulated pathogenic mechanism for T-cell non-Hodgkin lymphomas (T-NHL). The inducible T-cell costimulator (ICOS) is highly expressed by TFH, representing a potential target. MEDI
Autor:
Lillian L. Siu, Jeffrey A. Moscow, Gianluca Carlesso, Shringi Sharma, Weiping Shao, Enowmpey Enowtambong, Lisa Hewitt, Nathan Standifer, Lily Cheng, Weiguang Zhao, Anmarie Boutrin, Ling Zhang, Lisa Wang, Stephanie Zantinge, Ben X. Wang, Praveen Ramakrishnan Geethakumari, Neha Mehta-Shah, Harsh Shah, Joseph M. Tuscano, Jasmine M. Zain, Anca Prica, Sonali M. Smith, Jonathan E. Brammer, Basem M. William, Francine M. Foss, Julio C. Chavez
Supplemental Figure 2. MEDI-570 effects on lymphocyte and leukocyte populations. Baseline-normalized, absolute counts (ABS) of circulating cell populations were plotted on study days 1, 7, 14 and 21 from patients enrolled in each dose group as indica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3ce24c1e2410c2dc54c60bc33a6ba1
https://doi.org/10.1158/1078-0432.22820146.v1
https://doi.org/10.1158/1078-0432.22820146.v1
Autor:
Lillian L. Siu, Jeffrey A. Moscow, Gianluca Carlesso, Shringi Sharma, Weiping Shao, Enowmpey Enowtambong, Lisa Hewitt, Nathan Standifer, Lily Cheng, Weiguang Zhao, Anmarie Boutrin, Ling Zhang, Lisa Wang, Stephanie Zantinge, Ben X. Wang, Praveen Ramakrishnan Geethakumari, Neha Mehta-Shah, Harsh Shah, Joseph M. Tuscano, Jasmine M. Zain, Anca Prica, Sonali M. Smith, Jonathan E. Brammer, Basem M. William, Francine M. Foss, Julio C. Chavez
Supplemental Figure 1. CD4 count recovery after end of treatment (by local site collection)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2656d2baa634eb6a4b6411bc2d507120
https://doi.org/10.1158/1078-0432.22820149.v1
https://doi.org/10.1158/1078-0432.22820149.v1
Autor:
Lillian L. Siu, Jeffrey A. Moscow, Gianluca Carlesso, Shringi Sharma, Weiping Shao, Enowmpey Enowtambong, Lisa Hewitt, Nathan Standifer, Lily Cheng, Weiguang Zhao, Anmarie Boutrin, Ling Zhang, Lisa Wang, Stephanie Zantinge, Ben X. Wang, Praveen Ramakrishnan Geethakumari, Neha Mehta-Shah, Harsh Shah, Joseph M. Tuscano, Jasmine M. Zain, Anca Prica, Sonali M. Smith, Jonathan E. Brammer, Basem M. William, Francine M. Foss, Julio C. Chavez
Purpose:Proliferation of T-follicular helper (TFH) CD4+ T cells is a postulated pathogenic mechanism for T-cell non-Hodgkin lymphomas (T-NHL). The inducible T-cell costimulator (ICOS) is highly expressed by TFH, representing a potential target. MEDI-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040ed335d1799dde2795acdd87f16383
https://doi.org/10.1158/1078-0432.c.6563228
https://doi.org/10.1158/1078-0432.c.6563228
Autor:
Jimmy Zhijian, He, Hechuan, Wang, KyoungSoo, Lim, Song, Ren, Fred, Rollins, Markus, Vallaster, Ryan, Wong, Richard, Stebbings, Nathan, Standifer, Robert, Keefe, Alex, Phipps, Megan, Gibbs
Publikováno v:
Clinical Pharmacology in Drug Development. 11:1130-1135